470
Views
3
CrossRef citations to date
0
Altmetric
Original Research

The Protective Effects of Thymosin-β-4 in a Rat Model of Ischemic Acute Kidney Injury

, PhDORCID Icon, , PhD, , PhD, , PhD, , PhD, , PhD, , PhD, , PhD, , PhD, , PhD, , PhDORCID Icon, , PhD & , PhD show all
Pages 601-609 | Received 15 Aug 2019, Accepted 23 Sep 2019, Published online: 08 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Huseyin Kocaturk, Fevzi Bedir, Mehmet Sefa Altay, Ebubekir Bakan, Bahadir Suleyman, Gulce Naz Yazici, Mukadder Sunar, Zeynep Suleyman & Halis Suleyman. (2020) The effect of desloratadine on ischemia reperfusion induced oxidative and inflammatory renal injury in rats. Renal Failure 42:1, pages 531-538.
Read now

Articles from other publishers (2)

Jiahao Zhang, Minghui Long, Zhongyi Sun, Cheng Yang, Xiaofang Jiang, Li He, Lianjiu Su & Zhiyong Peng. (2021) Association between Thymosin beta-4, acute kidney injury, and mortality in patients with sepsis: An observational cohort study. International Immunopharmacology 101, pages 108167.
Crossref
Rui Yu, Yunyun Mao, Kai Li, Yanfang Zhai, Yue Zhang, Shuling Liu, Yuemei Gao, Zhengshan Chen, Yanhong Liu, Ting Fang, Mengsu Zhao, Ruihua Li, Junjie Xu & Wei Chen. (2021) Recombinant Human Thymosin Beta-4 Protects against Mouse Coronavirus Infection. Mediators of Inflammation 2021, pages 1-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.